The recent assault on the FDA’s jurisdiction on regulating off-label speech came to a head with the Amarin case. In that case, the FDA was told by a Judge in the 2nd Circuit that prohibiting “truthful and non-misleading” speech simply because it is disfavored is...

Last week we discussed Presidential candidates including Fmr. Sec. Hillary Clinton wanting to eliminate the tax breaks associated with advertising, or otherwise working to prohibit or otherwise minimize drug sales. Industry groups have, however, come out to defend...

Newsletter

Blog Disclaimer

The opinions stated in this blog are the sole and present opinions of the blogger and do not necessarily represent the opinions of the Kulkarni Law Firm, PC and/or its attorneys. Such opinion(s) may change over time. Such opinion(s) should not necessarily be attributed to the institution for which these individuals may work or otherwise represent in any capacity. These blogs do not constitute legal advice and should not be construed as such.